Diaceutics PLC (AIM:DXRX)
122.72
-2.28 (-1.82%)
Jun 17, 2025, 12:53 PM GMT+1
Diaceutics Revenue
In the year 2024, Diaceutics had annual revenue of 32.16M GBP with 35.69% growth. Diaceutics had revenue of 19.84M in the half year ending December 31, 2024, with 65.65% growth.
Revenue
32.16M
Revenue Growth
+35.69%
P/S Ratio
3.29
Revenue / Employee
161.60K
Employees
199
Market Cap
105.67M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 32.16M | 8.46M | 35.69% |
Dec 31, 2023 | 23.70M | 4.20M | 21.51% |
Dec 31, 2022 | 19.50M | 5.56M | 39.88% |
Dec 31, 2021 | 13.94M | 1.25M | 9.82% |
Dec 31, 2020 | 12.70M | -746.00K | -5.55% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |